SecSonar.com

AstraZeneca PLC (AZN)

AstraZeneca PLC at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AstraZeneca PLC (AZN) is a Drug Manufacturers - General company based in GB with a market capitalization of $288.5B. Revenue grew 8.6% year-over-year and the company generated $11.8B in free cash flow. This page tracks AZN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 94.3K employees · IPO May 12, 1993

Valuation

Valuation & price

$195.15 · as of Jul 4, 2026 · -6.8% vs 52w high

29.7

P/E ratio

Latest-FY diluted EPS

5.93

P/B ratio

Market cap ÷ book equity

1.83%

Dividend yield

Latest fiscal year

Price — last 12 months

$209$174$139Jul 25Dec 25Jul 26Jul 7, 25$142.63Jul 9, 25$141.40Jul 11, 25$140.26Jul 15, 25$140.40Jul 17, 25$138.52Jul 21, 25$139.70Jul 23, 25$147.30Jul 25, 25$145.32Jul 29, 25$150.48Jul 31, 25$147.39Aug 4, 25$150.32Aug 6, 25$148.68Aug 11, 25$146.12Aug 13, 25$154.30Aug 15, 25$155.50Aug 19, 25$159.08Aug 21, 25$160.92Aug 25, 25$162.98Aug 27, 25$160.65Aug 29, 25$161.13Sep 3, 25$162.26Sep 5, 25$164.50Sep 9, 25$160.54Sep 11, 25$162.00Sep 16, 25$153.00Sep 18, 25$153.39Sep 22, 25$156.82Sep 24, 25$149.04Sep 26, 25$146.16Sep 30, 25$149.50Oct 2, 25$164.68Oct 6, 25$172.30Oct 8, 25$172.10Oct 10, 25$169.34Oct 14, 25$169.10Oct 16, 25$169.12Oct 21, 25$168.28Oct 23, 25$168.24Oct 27, 25$163.99Oct 29, 25$163.68Oct 31, 25$164.80Nov 4, 25$165.26Nov 6, 25$169.00Nov 10, 25$174.90Nov 12, 25$175.66Nov 14, 25$174.82Nov 18, 25$175.20Nov 20, 25$177.85Nov 25, 25$187.72Nov 28, 25$183.74Dec 2, 25$179.10Dec 4, 25$180.06Dec 8, 25$180.94Dec 10, 25$181.92Dec 12, 25$179.66Dec 16, 25$182.70Dec 18, 25$180.54Dec 22, 25$180.75Dec 24, 25$186.40Dec 29, 25$187.06Jan 2, 26$182.68Jan 6, 26$190.49Jan 8, 26$188.50Jan 12, 26$185.48Jan 14, 26$190.23Jan 16, 26$191.13Jan 21, 26$175.00Jan 23, 26$177.50Jan 27, 26$188.07Jan 29, 26$183.17Feb 2, 26$188.41Feb 4, 26$187.45Feb 9, 26$188.01Feb 11, 26$204.76Feb 13, 26$205.55Feb 18, 26$208.67Feb 20, 26$204.20Feb 24, 26$206.61Feb 26, 26$203.98Mar 2, 26$203.73Mar 4, 26$201.53Mar 6, 26$194.22Mar 10, 26$194.99Mar 12, 26$192.50Mar 17, 26$191.29Mar 19, 26$188.93Mar 23, 26$184.07Mar 25, 26$187.14Mar 27, 26$188.42Mar 31, 26$197.22Apr 2, 26$203.49Apr 7, 26$200.81Apr 9, 26$204.99Apr 13, 26$202.24Apr 15, 26$201.21Apr 17, 26$204.80Apr 22, 26$194.81Apr 24, 26$189.75Apr 28, 26$186.68Apr 30, 26$187.37May 4, 26$183.46May 6, 26$184.92May 8, 26$182.85May 12, 26$184.54May 14, 26$184.96May 18, 26$183.92May 20, 26$187.46May 22, 26$187.03May 28, 26$185.33Jun 1, 26$179.71Jun 3, 26$176.28Jun 5, 26$185.95Jun 9, 26$183.43Jun 11, 26$182.28Jun 15, 26$177.27Jun 17, 26$177.89Jun 22, 26$176.43Jun 24, 26$183.02Jun 26, 26$188.41Jul 2, 26$195.15
$137.5852-week range$209.48
Loading valuation history…

Fundamentals

Key fundamentals

$288.5B

Market cap

8.6%

Revenue growth (YoY)

81.9%

Gross margin

$11.8B

Free cash flow (USD)

$24B

Net debt

0.0%

Share dilution

3/6

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$23.0BFY 2017$22.5BFY 2018$22.1BFY 2019$24.4BFY 2020$26.6BFY 2021$37.4BFY 2022$44.4BFY 2023$45.8BFY 2024$54.1BFY 2025$58.7B
$23B$58.7B

Free cash flow by year

2016 → 2025

FY 2016$1.8BFY 2017$2.0BFY 2018$1.2BFY 2019$509.0MFY 2020$2.2BFY 2021$3.8BFY 2022$7.2BFY 2023$6.6BFY 2024$7.3BFY 2025$11.8B
$1.8B$11.8B

Gross margin by year

2021 → 2025

FY 202166.8%FY 202272.1%FY 202382.0%FY 202481.1%FY 202581.9%
66.8%81.9%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 6-K filed Jun 15, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingAdmission of Further SecuritiesJul 1, 2026Filing
  • 6-K filingTotal Voting RightsJul 1, 2026Filing
  • 6-K filingRegulatory UpdateJun 29, 2026Filing
  • 6-K filingRegulatory UpdateJun 29, 2026Filing
  • Annual reportAnnual Report FiledJun 15, 2026Filing
  • 6-K filingTotal Voting RightsJun 1, 2026Filing
  • 6-K filingAdmission of Further SecuritiesJun 1, 2026Filing
  • Annual reportAnnual Report FiledMay 29, 2026Filing
  • Annual reportAnnual Report FiledMay 27, 2026Filing
  • Annual reportAnnual Report FiledMay 26, 2026Filing

Questions

Frequently asked questions

What is AstraZeneca PLC's market cap?

AstraZeneca PLC (AZN) has a market capitalization of $288.5B.

What is AZN's P/E ratio?

AZN trades at a price-to-earnings ratio of 29.7, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is AZN's price-to-book (P/B) ratio?

AZN trades at 5.93 times book value per share.

Does AstraZeneca PLC pay a dividend?

Yes — AZN paid roughly $3.21 per share in dividends over its latest fiscal year, a yield of about 1.83%.

Are insiders buying AZN stock?

SEC Form 4 filings show no open-market insider buys at AstraZeneca PLC in the last 90 days (1 sell).

Same arena

Related companies in Drug Manufacturers - General

NVS

Novartis AG

$287.1B

MRK

Merck & Co., Inc.

$293.4B

ABBV

AbbVie Inc.

$382B

AMGN

Amgen Inc.

$180.9B

GILD

Gilead Sciences, Inc.

$167.4B

PFE

Pfizer Inc.

$148.6B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.